Duramed Launches New Indication for ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) at North American Menopause Society Annu...(en with symptomsshould talk to their hea...),Health

Date:10/2/2007

en with symptoms should talk to their healthcare professional about finding a therapy that is right for them. For moderate to severe hot flashes and night sweats and moderate to severe vaginal atrophy, hormone therapy may be appropriate. If taking estrogen only for the symptoms of vaginal atrophy, topical treatment should be considered."

In addition to launching the new indication, the 0.9 mg tablet strength, approved by FDA in April, will now be added to the existing range of tablet dosing strengths which also includes 0.3 mg, 0.45 mg, 0.625 mg and 1.25 mg dosing strengths. This new dosage strength provides additional options for healthcare professionals and patients initiating oral estrogen therapy. Patients should be started at the lowest approved dose of 0.3 mg of ENJUVIA daily. Subsequent dosage adjustment (which will differ depending on the indication) and periodic reassessment may be made based upon the individual patient response. When prescribed solely for the treatment of symptoms of vulvar and vaginal atrophy, topical products should be considered.

Sources

(1) Menopause: The Journal of the North American Menopause Society

Vol. 14, No.3 pp. 357-358

(2) Bachman Ga, Ebert GA, Burd ID. Vulvovaginal Complaints. In: Lobo RA,

ed. Treatment of the Postmenopausal Woman: Basic and Clinical

Aspects. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins;

1999:195-201

About Menopause

Menopause is the time in a woman's life when the menstrual period ceases and the ovaries permanently stop releasing eggs. Menopause is considered complete when a woman has been without her period for a full year. While some women experience no menopausal symptoms, others suffer severe symptoms that require treatment. Vasomotor symptoms (night sweats, hot flashes) and vaginal symptoms such as vaginal dryness and pain with intercourse are common menopausal symptoms. Although the majority of women experience
'/>"/>

SOURCE Barr Pharmaceuticals, Inc. Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7
Related medicine news :

1. Glaxo launches pills to help smokers quit in 7-12 weeks
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. Dr Reddy’s Laboratories launches Hyalosy
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. Scottish Health Minister Launches Organ Donor Plan
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
8. Pfizer Launches Viagra For Lung Disease In UK
9. PM Launches Healthcare Foundation For India
10. African Union Launches A Programme On Acceleration of HIV Prevention
11. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms